In the world of biotechnology, there are numerous antibodies (both traditional and recombinant) that function, i.e., have practical applications in the real world.
Then there are immunology tools like the CD98 recombinant antibody. While these molecules are the backbone of breakthrough discoveries in cancer and autoimmune research, they carry a very specific legal and safety designation: Research Use Only (RUO).
Now, the question is why can’t these high-tech antibodies be used in a clinic yet?
Also, why is the distinction between a “lab tool” and a “medical treatment” so rigid?
This blog will explore the science behind CD98 and the critical reasons why RUO-grade antibodies are reserved strictly for lab tests.
What is CD98, and why is it Famous?
Before understanding the RUO label, it is also important to know exactly what CD98 is.
This is a “heavy chain” protein found on the surface of human cells, which is sometimes also referred to as SLC3A2. As for its working, it doesn’t work alone, i.e., it pairs with “light chains” to perform two vital life functions:
- Amino Acid Transport: It acts as a gatekeeper, bringing in the nutrients cells need to build proteins.
- Integrin Signaling: It helps cells stick to their environment and send signals for growth and survival.
Now, to understand why this protein is famous amongst researchers, you should know how cancer cells behave. Cancer cells need to grow fast, and they are always “hungry” for resources. To achieve this, cancer cells overexpress CD98.
And this is exactly why CD98 protein is a prime target for researchers trying to understand how to “starve” tumors or stop them from spreading.
Reasons Why CD98 Recombinant Antibody is “Research Use Only”
1. The Regulatory “Wall” (FDA vs. Lab Standards)
The primary reason for the RUO label is regulatory. A therapeutic drug must go through years of Clinical Trials and meet stringent FDA (or EMA) requirements for “Good Manufacturing Practice” (GMP). An RUO CD98 recombinant antibody is manufactured to high standards for scientific consistency, but it has not undergone the multi-billion-dollar process required to prove it is safe to inject into a human being.
2. Focus on “Functional Assays” over Pharmacology
In a lab setting, a researcher uses a functional assay to see if an antibody blocks CD98’s activity. The goal is to observe a biological change in a petri dish. However, a clinical goal for the same antibody would be to see if it can cure the patient without severe adverse effects, but since CD98 is not optimized for pharmacology, it is reserved as a RUO product.
3. Storage and Chemical Usage
To ensure CD98 recombinant antibodies are stable in a freezer, different concentrations and chemical buffers, like PBS, are used, which are obviously not formulated for human internal pH or tissue compatibility. Combining this with point #1, using CD98 antibody for clinical use is just not viable.
4. The Need for Experimental Flexibility
Research is about trial and error. Scientists need to use different concentrations, temperatures, and cell types (like Cynomolgus monkey cells or human cell lines) to see how CD98 behaves. Labeling a product as RUO allows manufacturers to provide these tools to scientists quickly without the 10-year delay of medical licensing, accelerating the pace of global discovery.
5. Safety and Liability
It should also be noted that the RUO label is not a restriction but a means to ensure the safety and liability of the antibody producer. Having an approved “research use only” label ensures that the antibody is limited to being used in a controlled environment, and if one happens to use it in a clinical setting, the manufacturer is not liable for the damage.
How Researchers Use CD98 Antibodies Today
While on the topic, it is also a good idea to know exactly what “research use only” applications the CD98 antibody has. Here are the three applications it is used for:
- Cancer Mapping: Using Flow Cytometry to see which types of lung or breast cancers have the most CD98.
- Immune Response: Studying how T-cells use CD98 to activate during an infection.
- Drug Discovery: Using the antibody as a “reference” to see if a new, experimental drug can bind to the same spot on the protein.